Autoantibodies in the detection and treatment of cancer

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01) A61K 39/395 (2006.01) G01N 33/53 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2725548

Methods, kits, and compositions for detecting and/or treating cancer based on detecting and/or administering an antibody, which can optionally be a bispecific antibody, having the immunoreaction characteristics of a cancer-associated autoantibody; an antigen for a cancer-associated autoantibody; or both an antibody having the immunoreaction characteristics of a cancer-associated autoantibody and an antigen for a cancer-associated autoantibody, in or to a subject in need thereof.

Linvention concerne des procédés, des kits et des compositions pour détecter et/ou traiter un cancer basés sur la détection et/ou ladministration dun anticorps, qui peut éventuellement être un anticorps bispécifique, ayant les caractéristiques dimmunoréaction dun auto-anticorps associé au cancer; un antigène pour un auto-anticorps associé au cancer; ou à la fois un anticorps ayant les caractéristiques dimmunoréaction dun auto-anticorps associé au cancer et un antigène pour un auto-anticorps associé au cancer, chez ou sur un sujet qui en a besoin.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Autoantibodies in the detection and treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Autoantibodies in the detection and treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Autoantibodies in the detection and treatment of cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1678366

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.